Searchable abstracts of presentations at key conferences in endocrinology

ea0063p176 | Diabetes, Obesity and Metabolism 1 | ECE2019

The waist-to-hip ratio is a better obesity index than body mass index and waist circumference for screening for nonalcoholic fatty liver disease in postmenopausal women

Yoo Hye Jin , Hong So-hyeon , Kim Jung A , Lee You-Bin , Roh Eun , Mook Choi Kyung , Baik Sei Hyun

Background/Objectives: Although it has been well-established that menopause causes a shift in body fat, thereby eliciting metabolic disturbances in women, there has been no study conducted yet to examine the best obesity parameters to predict the risk of nonalcoholic fatty liver disease (NAFLD) in this population. Thus, the aim of this study was to compare the efficacy of body mass index (BMI), waist circumference (WC), and waist-to-hip ratio (WHR) for screening NAFLD accordin...

ea0090p335 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Dapagliflozin Improves Glycemic control and Liver Function with Body Weight Loss as Add-on therapy to Metformin Plus Evogliptin: A 24-week, Randomized, Double-blind, Clinical Trial

Jeong In-Kyung , Mook Choi Kyung , Ah Han Kyung , Kim Kyoung-Ah , kim injoo , jin Han Seung , Wan Lee Byung , Lee Won-Young , Jib Yoo Soon

Background and aims: The efficacy and safety of dapagliflozin as add-on therapy in patients with type 2 diabetes mellitus (T2DM) and inadequate glycemic control with evogliptin and metformin combinations was investigated.Materials and methods: Patients with HbA1c of 7.0% to 10.5% receiving evogliptin 5mg and metformin ≥1000 mg were randomized to receive dapagliflozin 10 mg/day (n=99) or placebo (n=99) for 24 weeks. The primary end...